Dr. Ekerette J Essien, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 5206 Benito St Ste 216, Montclair, CA 91763 Phone: 909-660-3050 Fax: 888-235-1709 |
David Reynoso Psychologist - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5175 Flora St, Montclair, CA 91763 Phone: 442-666-4765 |
Dr. Frank James Trankina, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 11144 Buckskin Ave, Montclair, CA 91763 Phone: 909-627-3513 |
News Archive
The American Heart Association has awarded Cleveland Clinic a $3.7 million grant for atrial fibrillation research. The four-year, competitive award will support three synergistic projects aimed at improving outcomes for patients with atrial fibrillation, a common heart rhythm abnormality.
"Polypharmacy" is the term used when someone takes many (usually five or more) different medications. Experts suggest that, for most older adults, taking that many medications may not be medically necessary.
A woman's overall health before conception can impact her pregnancy and the health of her fetus.
The "crippling" and "growing burden" of communicable diseases such as dengue fever, polio, or meningitis is not being sufficiently addressed in developing countries, according to "The Epidemic Divide," a report released Monday by the International Federation of Red Cross and Red Crescent Societies (IFRC), AFP/Google.com reports. According to the report, resources to deal with existing epidemics are "scarce."
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 3 days ago